The Safety and Efficacy of Zileuton Controlled-Release Tablets as Adjunctive Therapy to Usual Care in the Treatment of Moderate Persistent Asthma: A 6-Month Randomized Controlled Study

Author： Wenzel Sally   Busse William   Calhoun William   Panettieri Reynold   Peters-Golden Mark   Dube Louise   Walton-Bowen Karen   Russell Heidy   Harris Judith  

Publisher： Informa Healthcare

ISSN： 0277-0903

Source： Journal of Asthma, Vol.44, Iss.4, 2007-05, pp. : 305-310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluticasone/Formoterol Combination Therapy versus Budesonide/Formoterol for the Treatment of Asthma: A Randomized, Controlled, Non-Inferiority Trial of Efficacy and Safety

By Bodzenta-Lukaszyk Anna   Buhl Roland   Balint Beatrix   Lomax Mark   Spooner Kay   Dissanayake Sanjeeva  

Journal of Asthma, Vol. 49, Iss. 10, 2012-12 ,pp. : 1060-1070

Informa Healthcare

Access to resources Recommend Favorite

Daclizumab Improves Asthma Control in Patients with Moderate to Severe Persistent Asthma: A Randomized, Controlled Trial

By Busse W. W.   Israel E.   Nelson H. S.  

Journal of Asthma, Vol. 46, Iss. 6, 2009-08 ,pp. : 634-634

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of Aclidinium Bromide Compared with Placebo and Tiotropium in Patients with Moderate-to-Severe Chronic Obstructive Pulmonary Disease: Results from a 6-week, Randomized, Controlled Phase Iiib Study

By Beier Jutta  

COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 10, Iss. 4, 2013-08 ,pp. : 511-522

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Safety of MLC601 in the Treatment of Mild Cognitive Impairment: A Pilot, Randomized, Double-Blind, Placebo-Controlled Study


By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 7, Iss. 1, 2017-05 ,pp. : 136-142

Karger

Access to resources Recommend Favorite

Effectiveness and Safety of MLC601 in the Treatment of Mild to Moderate Alzheimer's Disease: A Multicenter, Randomized Controlled Trial

By  

Dementia and Geriatric Cognitive Disorders Extra, Vol. 5, Iss. 1, 2015-03 ,pp. : 96-106

Karger

Access to resources Recommend Favorite